Mesa Laboratories 2024 Investor Presentation

Mesa Laboratories is a diversified life sciences tools company serving highly regulated markets, including biopharmaceutical, medical device, and clinical genomics sectors. The company reported $219M in FY23 revenues with a 23% three-year CAGR and 61% gross profit margin. The presentation outlines Mesa's strategy for organic growth through commercial execution and portfolio evolution while expanding exposure to high-growth verticals.